| 1 |
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
A. J. Tyndall et al. · Annals of the Rheumatic Diseases
Open access |
15 Jun 2010 |
1,461 |
| 2 |
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
Nicolino Ruperto et al. · The Lancet
|
15 Jul 2008 |
563 |
| 3 |
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial
Désirée M F M van der Heijde, Lars Klareskog, Vicente Rodrı́guez-Valverde et al. · Arthritis & Rheumatism
|
29 Mar 2006 |
545 |
| 4 |
Effects of Previous Antiresorptive Therapy on the Bone Mineral Density Response to Two Years of Teriparatide Treatment in Postmenopausal Women with Osteoporosis
Steven Boonen, Fernando Marín, Barbara Maria Obermayer-Pietsch et al. · The Journal of Clinical Endocrinology & Metabolism
|
26 Dec 2007 |
253 |
| 5 |
Long‐term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
Nicolino Ruperto et al. · Arthritis & Rheumatism
|
26 Feb 2010 |
240 |
| 6 |
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
Simon Bowman, Robert I. Fox, Thomas Dörner et al. · The Lancet
Open access |
30 Nov 2021 |
218 |
| 7 |
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study
Raúl Gutiérrez-Suárez et al. · Lara D. Veeken
Open access |
28 Jul 2006 |
175 |
| 8 |
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
Dragana Lazarević et al. · Annals of the Rheumatic Diseases
Open access |
27 Jun 2012 |
171 |
| 9 |
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
Christian Hubert Roux, Lorenz Christian Hofbauer, Pei‐Ran Ho et al. · Bone
Open access |
17 Oct 2013 |
159 |
| 10 |
Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real‐Life, International Systemic Lupus Erythematosus Cohort
Luís Inês et al. · Arthritis Care & Research
Open access |
7 Jan 2015 |
154 |
| 11 |
The Brazilian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).
Claúdia Saad Magalhäes Machado, Nicolino Ruperto, C. H M Silva et al. · PubMed
Open access |
8 Jan 2002 |
113 |
| 12 |
Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus
Mohammed Yousuf Karim, Luís Cunha-Miranda, Colin M. Tench et al. · Seminars in Arthritis and Rheumatism
|
Apr 2002 |
112 |
| 13 |
Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects
Fernando Manuel Pimentel-Santos, Dário Ligeiro, Mafalda Matos et al. · Arthritis Research & Therapy
Open access |
Apr 2011 |
105 |
| 14 |
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis
Nicolino Ruperto et al. · Arthritis Care & Research
Open access |
25 Jun 2010 |
96 |
| 15 |
Long‐Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years
Daniel J. Lovell et al. · Arthritis & Rheumatology
Open access |
20 Jun 2015 |
90 |
| 16 |
Association study of IL10 and IL23R–IL12RB2 in Iranian patients with Behçet's disease
Joana M. Xavier, Farhad Shahram, Fereydoun Davatchi et al. · Arthritis & Rheumatism
|
29 Feb 2012 |
83 |
| 17 |
Dietary interventions in fibromyalgia: a systematic review
Ana Rita Silva, Alexandra Bernardo, João Costa et al. · Annals of Medicine
ReviewOpen access |
8 Feb 2019 |
78 |
| 18 |
Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage
Filipa Oliveira‐Ramos, Mónica Eusébio, Fernando Martins et al. · RMD Open
Open access |
Sep 2016 |
75 |
| 19 |
Reuma.pt - the rheumatic diseases portuguese register.
Helena M Canhão, Augusto Faustino, Fernando Martins et al. · PubMed
|
17 Aug 2011 |
74 |
| 20 |
Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register
Sandra Sousa et al. · Rheumatology International
|
15 Mar 2016 |
70 |
| 21 |
Relationship between leptin and body mass and metabolic syndrome in an adult population
Maria do Carmo de Carvalho e Martins, Luís Lima Faleiro, Aidil Fonseca · Revista Portuguesa de Cardiologia (English Edition)
Open access |
23 Oct 2012 |
65 |
| 22 |
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
Elsa Vieira‐Sousa et al. · Annals of the Rheumatic Diseases
Open access |
19 Mar 2020 |
64 |
| 23 |
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration
Brigitte Michelsen et al. · RMD Open
Open access |
Sep 2020 |
62 |
| 24 |
Validation of Relapse Risk Biomarkers for Routine Use in Patients With Juvenile Idiopathic Arthritis
Friederike Rothmund et al. · Arthritis Care & Research
|
10 Dec 2013 |
57 |
| 25 |
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling
Claire T. Deakin, Raquel Campanilho‐Marques, Stefania Simou et al. · Arthritis & Rheumatology
Open access |
17 Jan 2018 |
55 |
| 26 |
Capillarosecopic patterns in rheumatic diseases.
Sara Cortés Gómez, Maurizio Cutolo · PubMed
|
21 Jun 2007 |
55 |
| 27 |
Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO)
Cyrus Cooper, Franz Josef Jakob, Chris Chinn et al. · Osteoporosis International
|
29 Oct 2007 |
51 |
| 28 |
Growth and Puberty in Juvenile Dermatomyositis: A Longitudinal Cohort Study
Ellen Berit Nordal et al. · Arthritis Care & Research
|
10 Sep 2019 |
43 |
| 29 |
Relação entre a leptina, a massa corporal e a síndrome metabólica numa amostra da população adulta
Maria do Carmo de Carvalho e Martins, Luís Lima Faleiro, Aidil Fonseca · Revista Portuguesa de Cardiologia
Open access |
3 Oct 2012 |
42 |
| 30 |
Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol
Joseph V. Pergolizzi, Cayetano Alegre, David R. Blake et al. · Pain Practice
|
29 Jul 2011 |
42 |
| 31 |
Bone density after teriparatide in patients with or without prior antiresorptive treatment: one-year results from the EUROFORS study*
Helmut W. Minne, Maurice Audran, Maria E. Simões et al. · Current Medical Research and Opinion
|
6 Oct 2008 |
38 |
| 32 |
Common Evaluations of Disease Activity in Rheumatoid Arthritis Reach Discordant Classifications across Different Populations
Helena M Canhão, Ana Maria Rodrigues, Maria João Gregório et al. · Frontiers in Medicine
Open access |
7 Mar 2018 |
37 |
| 33 |
PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it
Nicolino Ruperto et al. · Annals of the Rheumatic Diseases
Open access |
11 Mar 2005 |
35 |
| 34 |
NEAR study: Needs and Expectations in Rheumatoid ARthritis - do we know our patients needs?
Luís Cunha-Miranda, Lúcia Costa, José Saraiva Ribeiro · PubMed
|
28 Feb 2011 |
35 |
| 35 |
Effect of Comedication With Conventional Synthetic Disease‐Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study
Alexandre Rocha Sepriano et al. · Arthritis & Rheumatology
Open access |
6 Jun 2016 |
32 |
| 36 |
Characterization of damage in Portuguese lupus patients: analysis of a national lupus registry
Anabela Susana de Sousa Gonçalves et al. · Lupus
|
15 Oct 2014 |
32 |
| 37 |
Tear Meniscus and Corneal Sub-basal Nerve Plexus Assessment in Primary Sjögren Syndrome and Sicca Syndrome Patients
Joana Cardigos, Filipe Barcelos, Helena Carvalho et al. · Cornea
Open access |
30 Oct 2018 |
31 |
| 38 |
Effectiveness and long-term retention of anti-tumour necrosis factor treatment in juvenile and adult patients with juvenile idiopathic arthritis: data from Reuma.pt
Ana Filipa Mourão, María José Santos, José António Melo Gomes et al. · Lara D. Veeken
Open access |
15 Dec 2015 |
31 |
| 39 |
Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries
P.A. Laires, Fernando Gustavo Exposto, Ricardo N. O. Mesquita et al. · The European Journal of Health Economics
|
17 Sep 2012 |
31 |
| 40 |
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
Lykke Midtbøll Ørnbjerg et al. · Seminars in Arthritis and Rheumatism
Open access |
10 Aug 2022 |
30 |
| 41 |
Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register
Sytske Anne Bergstra, Cornelia F Allaart, Sofía Ramiro et al. · The Journal of Rheumatology
Open access |
15 Jun 2018 |
29 |
| 42 |
From PsO to PsA: the role of TRM and Tregs in psoriatic disease, a systematic review of the literature
Bárbara Lobão, Diana Lourenço, Ana Giga et al. · Frontiers in Medicine
ReviewOpen access |
8 Feb 2024 |
28 |
| 43 |
Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study
Andréa Marques, Raquel Lucas, Eugénia Simões et al. · RMD Open
Open access |
Sep 2017 |
28 |
| 44 |
Two separate effects contribute to regulatory T cell defect in systemic lupus erythematosus patients and their unaffected relatives
Nicole Beatriz Lopes Damascena Costa, Oriana Marques, Sandra Íris Sanches Godinho et al. · Clinical & Experimental Immunology
Open access |
25 May 2017 |
27 |
| 45 |
Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
Jaime Branco, Anabela Barcelos, Filipe Pombo de Araújo et al. · Advances in Therapy
Open access |
2016 |
27 |
| 46 |
Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register
Elsa Vieira‐Sousa, Mónica Eusébio, Pedro Ávila-Ribeiro et al. · The Journal of Rheumatology
|
Aug 2019 |
26 |
| 47 |
Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52‐Week Results From a Randomized, Placebo‐Controlled, Phase 2b Dose‐Ranging Study
Thomas Dörner, Simon Bowman, Robert I. Fox et al. · Arthritis & Rheumatology
|
18 Nov 2024 |
25 |
| 48 |
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
Santiago Rodrigues-Manica, Alexandre Rocha Sepriano, Fernando Manuel Pimentel-Santos et al. · Arthritis Research & Therapy
Open access |
21 Aug 2020 |
25 |
| 49 |
Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt
Vasco C. Romão, María José Santos, Joaquim Polido Pereira et al. · BioMed Research International
Open access |
2015 |
25 |
| 50 |
Inadequate pain relief among patients with primary knee osteoarthritis
P.A. Laires, Jorge Laíns, Luís Cunha-Miranda et al. · Revista Brasileira de Reumatologia (English Edition)
Open access |
5 Dec 2016 |
24 |